More on Sanofi (SNY +3.2%) Q2: adjusted net profit -9.6% to €1.94B, hurt by patent expirations for Plavo and Avapro. Plans to announce details of job cuts at two French units in September, putting it on a collision course with the government, which says it won't tolerate job losses at profitable companies.